Farhad Khimani

7PUBLICATIONS
84CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyCardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 17, 2026
A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.

|Apr 08, 2026
Single center evaluation of a composite risk assessment model to predict non-relapse mortality following allogeneic hematopoietic cell transplantation (HCT).

Reshma Ramlal, Jongphil Kim, Zachary Thompson

|Jul 05, 2025
Letermovir reduces cytomegalovirus in HLA-matched and mismatched allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide.

Jena Schmitz, Eric Gaskill, Samantha Price

|Jun 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.

Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan

|Apr 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.

Khushali Jhaveri, Ram Thapa, Dalia Ercan

|Jul 17, 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.

Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor

Pageof 2

Frequent Collaborators

5 joint publications

Aleksandr Lazaryan

5 joint publications

Taiga Nishihori

4 joint publications

Frederick Locke

3 joint publications

Michael Jain